Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience

被引:32
|
作者
Teh, Cheng Lay [1 ]
Phui, Vui Eng [2 ]
Ling, Guo Ruey [3 ]
Ngu, Lui-Sian [2 ]
Wan, Sharifah Aishah [1 ]
Tan, Clare Hui-Hong [2 ]
机构
[1] Sarawak Gen Hosp, Dept Med, Rheumatol Unit, Sarawak, Malaysia
[2] Sarawak Gen Hosp, Dept Med, Nephrol Unit, Sarawak, Malaysia
[3] Sibu Hosp, Dept Med, Rheumatol Unit, Sarawak, Malaysia
关键词
dialysis; lupus nephritis; mortality; outcome; systemic lupus erythematosus; PROGNOSTIC-FACTORS; RENAL OUTCOMES; CLASSIFICATION; ERYTHEMATOSUS; COHORT; RISK;
D O I
10.1093/ckj/sfx063
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus that can be fatal if left untreated. The causes and prognostic predictors of mortality in LN have been well studied in developed countries but evidence is lacking for developing countries. The objective of this study was to investigate the causes and predictors of mortality in a cohort of Malaysian patients with biopsy-proven LN. Methods: We retrospectively studied all patients with biopsy-proven LN treated in Sarawak General Hospital during the period of 2000-15. Demographic data, clinical features and outcomes were collected. Cox regression analysis was carried out to determine the independent predictors of mortality. Results: There was a total of 250 patients with 259 renal biopsies available for our analysis. Our patients were of multiethnic origins with a female predominance (90%). Their mean 6 standard deviation age was 37.7 +/- 12.8 years. The patients had a mean disease duration of 135.6 +/- 81.9 months. Nephrotic syndrome was the most common presentation (29.6%) and acute renal failure was evident at initial presentation in 16% of patients. Class IV LN was the predominant biopsy class within the cohort (66.8%). The majority of patients achieved remission (81.2%) and had normal renal function (83.9%) at the last follow-up. The 5-, 10-, 15- and 20-year survival rates for our cohort were 93%, 88%, 82% and 77%, respectively. There were 37 deaths (14.8%), of which the main causes were: infection and flare (52.7%), infection alone (25.0%) and other causes (22.3%). Independent predictors of mortality in our cohort of LN patients were: the presence of acute kidney injury at presentation [ hazard ratio (HR) 3.41; confidence interval (CI) 1.50-7.76], failure to achieve remission at 1-year post-induction therapy (HR 2.99; CI 1.35-6.65) and non-compliance with treatment (HR 1.89; CI 1.22-2.96). Age, ethnicity, class of LN and type of immunosuppressant used were not predictive of mortality. Conclusions: Survival and renal outcomes in our LN cohort were comparable to most LN studies reported worldwide. Both flare and infection remained the main causes of death. The presence of acute renal failure at presentation, failure to achieve remission at 1 year post-treatment and non-compliance with treatment were independent prognostic predictors of mortality in LN.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 50 条
  • [1] OUTCOME IN BIOPSY-PROVEN LUPUS NEPHRITIS
    Mjoen, Geir
    Norby, Gudrun E.
    Vikse, Bjorn Egil
    Svarstad, Einar
    Rune, Bjoerneklett
    Knut, Aasaroed
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 182 - 182
  • [2] Lymphangiogenesis in Biopsy-Proven Lupus Nephritis
    Yeom, Jihyun
    Kang, Kyung Pyo
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 499 - 499
  • [3] Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis
    Ayodele, Olugbenga Edward
    Okpechi, Ikechi G.
    Swanepoel, Charles R.
    [J]. NEPHROLOGY, 2010, 15 (04) : 482 - 490
  • [4] Predictors of Earlier Time to Renal Failure Among Those with Biopsy-Proven Lupus Nephritis
    Duarte-Garcia, Ali
    Fang, Hong
    Magder, Laurence S.
    Petri, Michelle
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S542 - S542
  • [5] Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
    Satirapoj, Bancha
    Tasanavipas, Pamila
    Supasyndh, Ouppatham
    [J]. INTERNATIONAL JOURNAL OF NEPHROLOGY, 2015, 2015
  • [6] Long-term outcome of biopsy-proven lupus nephritis in Iran
    Fatemi, Alimohammad
    Kazemi, Mehdi
    Sayedbonakdar, Zahra
    Farajzadegan, Ziba
    Karimzadeh, Hadi
    Moosavi, Mahdi
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (06) : 739 - 746
  • [7] Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis
    Hara, Akinori
    Furuichi, Kengo
    Yamahana, Junya
    Yasuda, Haruka
    Iwata, Yasunori
    Sakai, Norihiko
    Shimizu, Miho
    Kaneko, Shuichi
    Wada, Takashi
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (07) : 1328 - 1334
  • [8] Biopsy-proven paediatric tubulointerstitial nephritis
    Marianella Howell
    Neil J. Sebire
    Stephen D. Marks
    Kjell Tullus
    [J]. Pediatric Nephrology, 2016, 31 : 1625 - 1630
  • [9] Predictors of Mortality in Patients With Biopsy-Proven Cardiac AL Amyloidosis
    Koutroumpakis, Efstratios
    Niku, Adam
    Black, Christopher K.
    Sadaf, Humaira
    Song, Juhee
    Palaskas, Nicolas L.
    Iliescu, Cezar
    Durand, Jean-Bernard
    Deswal, Anita M.
    Buja, Louis M.
    Banchs, Jose
    [J]. CIRCULATION, 2022, 146
  • [10] The prevalence and incidence of biopsy-proven lupus nephritis in the UK - Evidence of an ethnic gradient
    Patel, Mumtaz
    Clarke, Alexandra M.
    Bruce, Ian N.
    Symmons, Deborah P. M.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2963 - 2969